These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18365691)

  • 1. Expression and purification of human papillomavirus 18 L1 virus-like particle from saccharomyces cerevisiae.
    Woo MK; An JM; Kim JD; Park SN; Kim HJ
    Arch Pharm Res; 2008 Feb; 31(2):205-9. PubMed ID: 18365691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for removing contaminating protein during purification of human papillomavirus type 18 L1 protein from Saccharomyces cerevisiae.
    Kim HJ; Lim SJ; Kim JY; Kim SY; Kim HJ
    Arch Pharm Res; 2009 Dec; 32(12):1759-66. PubMed ID: 20162405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae.
    Kim SN; Jeong HS; Park SN; Kim HJ
    J Virol Methods; 2007 Jan; 139(1):24-30. PubMed ID: 17034867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae.
    Park MA; Kim HJ; Kim HJ
    Protein Expr Purif; 2008 May; 59(1):175-81. PubMed ID: 18343683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and immunogenicity study of human papillomavirus 58 virus-like particles expressed in Pichia pastoris.
    Jiang Z; Tong G; Cai B; Xu Y; Lou J
    Protein Expr Purif; 2011 Dec; 80(2):203-10. PubMed ID: 21821128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli].
    Xie M; Li S; Shen W; Li Z; Zhuang Y; Mo X; Gu Y; Wu T; Zhang J; Xia N
    Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1082-7. PubMed ID: 19835152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae.
    Kim HJ; Lee SJ; Kim HJ
    J Biotechnol; 2010 Oct; 150(1):31-6. PubMed ID: 20696192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
    Baek JO; Seo JW; Kim IH; Kim CH
    Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine.
    Deschuyteneer M; Elouahabi A; Plainchamp D; Plisnier M; Soete D; Corazza Y; Lockman L; Giannini S; Deschamps M
    Hum Vaccin; 2010 May; 6(5):407-19. PubMed ID: 20953154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs).
    Mach H; Volkin DB; Troutman RD; Wang B; Luo Z; Jansen KU; Shi L
    J Pharm Sci; 2006 Oct; 95(10):2195-206. PubMed ID: 16871523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.
    Gu Y; Wei M; Wang D; Li Z; Xie M; Pan H; Wu T; Zhang J; Li S; Xia N
    Vaccine; 2017 Aug; 35(35 Pt B):4637-4645. PubMed ID: 28736197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae.
    Kim HJ; Kim SY; Lim SJ; Kim JY; Lee SJ; Kim HJ
    Protein Expr Purif; 2010 Mar; 70(1):68-74. PubMed ID: 19686852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
    Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
    Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris.
    Bazan SB; de Alencar Muniz Chaves A; Aires KA; Cianciarullo AM; Garcea RL; Ho PL
    Arch Virol; 2009; 154(10):1609-17. PubMed ID: 19756360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development a scalable production process for truncated human papillomavirus type-6 L1 protein using WAVE Bioreactor and hollow fiber membrane.
    Sun B; Zhao D; Zhang X; Gu T; Yu X; Sun S; Zhao X; Wei L; Liu D; Yan H; Meng X; Kong W; Xu F; Yang P; Jiang C
    Appl Microbiol Biotechnol; 2016 Feb; 100(3):1231-1240. PubMed ID: 26446387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae.
    Cook JC; Joyce JG; George HA; Schultz LD; Hurni WM; Jansen KU; Hepler RW; Ip C; Lowe RS; Keller PM; Lehman ED
    Protein Expr Purif; 1999 Dec; 17(3):477-84. PubMed ID: 10600468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins.
    Buonamassa DT; Greer CE; Capo S; Yen TS; Galeotti CL; Bensi G
    Virology; 2002 Feb; 293(2):335-44. PubMed ID: 11886254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.